FRM
NVAX icon

Fox Run Management’s Novavax NVAX Stock Holding History

Fox Run Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-74,655
Closed -$479K – 1108
2025
Q1 		$479K Buy
+74,655
New +$617K 0.07% 517
2024
Q4 		– Sell
-11,069
Closed -$140K – 1080
2024
Q3 		$140K Sell
11,069
-5,105
-32% -$65.9K 0.03% 709
2024
Q2 		$205K Buy
+16,174
New +$163K 0.04% 670
2023
Q4 		– Sell
-10,012
Closed -$72.5K – 930
2023
Q3 		$72.5K Buy
+10,012
New +$80K 0.02% 648
2022
Q4 		– Sell
-10,322
Closed -$188K – 808
2022
Q3 		$188K Buy
+10,322
New +$447K 0.07% 492
2022
Q2 		– Sell
-4,596
Closed -$338K – 680
2022
Q1 		$338K Buy
+4,596
New +$410K 0.19% 227
2021
Q1 		– Sell
-1,863
Closed -$208K – 285
2020
Q4 		$208K Buy
+1,863
New +$198K 0.42% 137

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fox Run Management's NVAX Position: Q2 2025 in Review

Fox Run Management sold out of Novavax (NVAX) in Q2 2025, closing a stake of 74,655 shares — an estimated $479K sold.

Fox Run Management first reported a position in NVAX in Q4 2020 and held it in 7 quarters. The position peaked at $479K in Q1 2025. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • Fox Run Management reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
  • Fox Run Management sold 74,655 Novavax shares in Q2 2025, an estimated $479K.
  • Fox Run Management first reported a position in Novavax in Q4 2020 and held it in 7 quarters.
  • Fox Run Management's Novavax position peaked at $479K in Q1 2025.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Fox Run Management's 13F filing for Q2 2025, filed 6 Aug 2025.